GLP-1 prescriptions for weight loss are shooting up, despite obstacles
- GLP-1 drug prescriptions for overweight and obese adults in the US increased sharply from 0.3% in 2019 to 2.05% in 2024, based on commercial claims data.
- This rise occurred amid longstanding obesity challenges and limited treatment access, with over 80% of patients lacking GLP-1 drugs, surgery, or behavioral care in 2024.
- Three GLP-1 drugs—Saxenda, Wegovy, and Zepbound—are FDA-approved for weight management, with Novo Nordisk and Eli Lilly leading sales but facing supply and market competition issues.
- Novo Nordisk reported $9.9 billion and Eli Lilly $4.9 billion in 2024 GLP-1 sales, while the increasing prescriptions coincided with falling bariatric surgery and behavioral health service rates.
- These trends suggest GLP-1 drugs may be replacing other obesity treatments, raising concerns about access, safety of compounded versions, and implications for healthcare stakeholders.
12 Articles
12 Articles
Slimming Injection Miracle Cure for 'Fatman of Europe', but Dangerous on Black Market
It has been called a 'miracle drug': a drug that mimics the body's own hormone GLP-1, which tells the brain that you are full. It is found in slimming injections such as Ozempic, Wegovy and Mounjaro. Sheila Hogen from Dunbar, Scotland, is one of the half a million Britons who have already used the slimming drug. Every week, she injects the drug into her stomach with an injection pen. She weighed 110 kilos, was pre-diabetic, had osteoarthritis, h…
FINALLY: An Oral Spray Designed to Help Melt the Pounds Away! * 100PercentFedUp.com * by Noah
Summer is finally here! The bad news is that for many of us, the New Years resolutions are a distant memory and the reality is that we still have extra weight we would like to drop before we hit the beach or the pool or the lake. The good news is that you can still do something to drop that weight – without the needles! Semaglutide – A clinically-trusted GLP-1 receptor agonist, is now available in a fast-acting oral spray. It helps reduce appeti…
FINALLY: An Oral Spray Designed to Help Melt the Pounds Away!
Summer is finally here! The bad news is that for many of us, the New Years resolutions are a distant memory and the reality is that we still have extra weight we would like to drop before we hit the beach or the pool or the lake. The good news is that you can still do something to drop that weight – without the needles! Semaglutide – A clinically-trusted GLP-1 receptor agonist, is now available in a fast-acting oral spray. It helps reduce appeti…
Fake Weight-Loss Drugs Are Flooding Florida, State Leaders Must Act Now
More than one million adults in Florida are using injectable GLP-1 drugs to fight obesity—making the state one of the largest markets for these transformative medicines. Many patients, with the supervision of their doctor, take FDA-approved brand name medications. I’ve seen the results firsthand. These drugs change lives—helping people transform their bodies and overall health. […] Fake Weight-Loss Drugs Are Flooding Florida, State Leaders Must …
Weight loss drugs like Ozempic could soon be in reach
By Lindsey Banks At Carolina Family Healthcare in Charlotte, family physician Dimitrios Hondros has seen firsthand the life-changing benefits of weight loss drugs like Ozempic and Wegovy. Patients not only lose weight but also often see improvements in blood pressure, cholesterol and blood sugar — factors that reduce their risk for heart disease and diabetes. Yet Hondros estimates that 30 percent to 40 percent of his patients who could benefit f…
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous with a booming weight loss drug market that could hit $139 billion by 2030.Read more...
Coverage Details
Bias Distribution
- 57% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage